| 1 |
Zhan Y, Tao Q, Meng Q, Zhang R, Lin L, Li X, Zheng L, Zheng J. LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition. Commun Biol 2023;6:285. [PMID: 36934152 DOI: 10.1038/s42003-023-04670-z] [Reference Citation Analysis]
|
| 2 |
Chen H, Zhou X, Yang Y, Feng Y. Shen Qi Wan-Containing Serum Alleviates Renal Interstitial Fibrosis via Restraining Notch1-Mediated Epithelial-Mesenchymal Transition. Evid Based Complement Alternat Med 2023;2023:3352353. [PMID: 36793762 DOI: 10.1155/2023/3352353] [Reference Citation Analysis]
|
| 3 |
Liu C, Ma K, Zhang Y, He X, Song L, Chi M, Han Z, Li G, Zhang Q, Liu C. Kidney diseases and long non-coding RNAs in the limelight. Front Physiol 2022;13:932693. [DOI: 10.3389/fphys.2022.932693] [Reference Citation Analysis]
|
| 4 |
Li Y, Zhang L, Xiong W, Gao X, Xiong Y, Sun W, Liao Z. A Molecular Mechanism Study to Reveal Hirudin’s Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFRβ in Renal Fibrosis Treatment. BioMed Research International 2022;2022:1-14. [DOI: 10.1155/2022/5481552] [Reference Citation Analysis]
|
| 5 |
Xu D, Li H, Katsube T, Huang G, Liu J, Wang B, Zhang H. Effects of Concurrent Exposure to Chronic Restraint-Induced Stress and Total-Body Iron Ion Radiation on Induction of Kidney Injury in Mice. Int J Mol Sci 2022;23:4866. [PMID: 35563256 DOI: 10.3390/ijms23094866] [Reference Citation Analysis]
|
| 6 |
Zhang YY, Tan RZ, Yu Y, Niu YY, Yu C. LncRNA GAS5 protects against TGF-β-induced renal fibrosis via the Smad3/miRNA-142-5p axis. Am J Physiol Renal Physiol 2021;321:F517-26. [PMID: 34486400 DOI: 10.1152/ajprenal.00085.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Xia W, He Y, Gan Y, Zhang B, Dai G, Ru F, Jiang Z, Chen Z, Chen X. Long Non-coding RNA: An Emerging Contributor and Potential Therapeutic Target in Renal Fibrosis. Front Genet 2021;12:682904. [PMID: 34386039 DOI: 10.3389/fgene.2021.682904] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 8 |
Wang Z, Chen Z, Li B, Zhang B, Du Y, Liu Y, He Y, Chen X. Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4/NF-кB and PI3K/AKT signalling pathways. Pharm Biol 2020;58:828-37. [PMID: 32866059 DOI: 10.1080/13880209.2020.1809462] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 9 |
Moreno JA, Hamza E, Guerrero-Hue M, Rayego-Mateos S, García-Caballero C, Vallejo-Mudarra M, Metzinger L, Metzinger-Le Meuth V. Non-Coding RNAs in Kidney Diseases: The Long and Short of Them. Int J Mol Sci 2021;22:6077. [PMID: 34199920 DOI: 10.3390/ijms22116077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 10 |
Gu YY, Dou JY, Huang XR, Liu XS, Lan HY. Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis. Front Physiol 2021;12:684236. [PMID: 34054586 DOI: 10.3389/fphys.2021.684236] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Zhang M, Zhao S, Xu C, Shen Y, Huang J, Shen S, Li Y, Chen X. Ablation of lncRNA MIAT mitigates high glucose-stimulated inflammation and apoptosis of podocyte via miR-130a-3p/TLR4 signaling axis. Biochemical and Biophysical Research Communications 2020;533:429-36. [DOI: 10.1016/j.bbrc.2020.09.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 12 |
Jia H, Ma T, Hao C. Identification of candidate lncRNA biomarkers for renal fibrosis: A systematic review. Life Sci 2020;262:118566. [PMID: 33038373 DOI: 10.1016/j.lfs.2020.118566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Yang N, Cao DF, Yin XX, Zhou HH, Mao XY. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases. Biomed Pharmacother 2020;131:110791. [PMID: 33152948 DOI: 10.1016/j.biopha.2020.110791] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Cao L, Qin P, Zhang J, Qiao H, Shi P, Huo H. LncRNA PVT1 Suppresses the Progression of Renal Fibrosis via Inactivation of TGF-β Signaling Pathway. Drug Des Devel Ther 2020;14:3547-57. [PMID: 32921988 DOI: 10.2147/DDDT.S245244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Lin J, Jiang Z, Liu C, Zhou D, Song J, Liao Y, Chen J. Emerging Roles of Long Non-Coding RNAs in Renal Fibrosis. Life (Basel) 2020;10:E131. [PMID: 32752143 DOI: 10.3390/life10080131] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 16 |
Zhou Z, Zhang S, Xiong Y. Long noncoding RNA MIAT promotes non-small cell lung cancer progression by sponging miR-149-5p and regulating FOXM1 expression. Cancer Cell Int 2020;20:348. [PMID: 32742195 DOI: 10.1186/s12935-020-01432-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
